Visugromab for cancer-related weight loss
Treatments studied
Part of Cancer clinical trials.
This trial tests a medicine called visugromab for people with advanced cancer who have also lost weight. It aims to help with that weight loss (cachexia) and potentially improve your quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lost some weight without trying.
- You have advanced cancer.
- You have not been in another clinical trial or taken any experimental drug in the past 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if adding a weight loss medication (tirzepatide or semaglutide) during chemotherapy helps people with early-stage endometrial cancer who are overweight or have diabetes. It aims to see if weight loss can improve treatment outcomes.
This trial tests an experimental drug called visugromab added to standard chemotherapy and immunotherapy for people newly diagnosed with advanced non-squamous lung cancer. It aims to see if the combination works better than standard treatment alone.
This study tests a new medicine (QLS2319) to see if it’s safe and can help people with cancer-related weight loss and muscle loss (cachexia). It’s for people whose daily activities aren’t severely limited by their cancer.
This study tests a new medicine called ponsegromab to see if it can help stop weight loss in people with advanced lung cancer. It is given alongside your usual immunotherapy and may help you maintain your strength and quality of life.
This Phase 1 trial tests a new drug called GB18 to help cancer patients who have experienced significant weight loss and muscle wasting—a condition called cancer cachexia. The drug works by targeting a specific protein involved in weight loss, and researchers want to learn if it can help patients regain weight and strength while also being safe.
This study tests a new drug called DS010 to see if it can help people with cancer-related weight loss and muscle loss (cachexia). The goal is to improve appetite and strength, which may help you feel better during cancer treatment.
Hear when a new Cancer-associated Cachexia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.